A review on therapeutic drug monitoring of the mTOR class of immunosuppressants: everolimus and sirolimus

about

A review on therapeutic drug monitoring of the mTOR class of immunosuppressants: everolimus and sirolimus

Item

http://www.wikidata.org/entity/Q56035477

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у квітні 2017

@uk

ലേഖനം

@ml

name

A review on therapeutic drug m ...... ants: everolimus and sirolimus

@en

A review on therapeutic drug m ...... ants: everolimus and sirolimus

@nl

type

Item

label

A review on therapeutic drug m ...... ants: everolimus and sirolimus

@en

A review on therapeutic drug m ...... ants: everolimus and sirolimus

@nl

prefLabel

A review on therapeutic drug m ...... ants: everolimus and sirolimus

@en

A review on therapeutic drug m ...... ants: everolimus and sirolimus

@nl

P1476

A review on therapeutic drug m ...... ants: everolimus and sirolimus

@en

P2093

Anroop B. Nair

http://www.w3.org/2001/XMLSchema#string

P2860

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Therapeutic drug monitoring for everolimus in kidney transplantation using 12-month exposure, efficacy, and safety data.

Efficacy and safety of Everolimus in children with TSC - associated epilepsy - Pilot data from an open single-center prospective study.

Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.

Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity.

De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination.

Review of the proliferation inhibitor everolimus.

Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure.

Clinical pharmacokinetics of everolimus.

Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients.

P2888

s40267-017-0403-0

P304

290-301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40267-017-0403-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shery Jacob

P577

2017-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

immunosuppression